Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- AstraZeneca
- Study ID
- NCT07431281
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Esophageal Cancer
- Gastric Cancer
- Gastroesophageal Junction Adenocarcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Sonesitatug vedotin — DRUGIntravenous
- Rilvegostomig — DRUGIntravenous
- Nivolumab — DRUGIntravenous
- Capecitabine — DRUGOral
- 5-Fluorouracil — DRUGIntravenous
- Oxaliplatin — DRUGIntravenous
- Zolbetuximab — DRUGIntravenous
- Leucovorin — DRUGIntravenous
Study Details
The purpose of this study is to evaluate the efficacy and safety of sonesitatug vedotin in combination with capecitabine with or without rilvegostomig in first-line (1L) Claudin18.2 (CLDN18.2)-positive, human epidermal growth factor receptor 2 (HER2)-negative, gastric, gastroesophageal junction (GEJ), and esophageal adenocarcinoma.
Key Dates
- Start date
- Feb 3, 2026
- Status verified
- May 2026
- Primary completion
- Aug 16, 2029
- Completion
- Oct 27, 2031
Study Design
- Enrollment
- 2,130 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Arm ASonesitatug vedotin + Rilvegostomig + Capecitabine
- Experimental: Arm BSonesitatug vedotin + Nivolumab + Capecitabine
- Active Comparator: Arm CNivolumab + CAPOX OR Nivolumab + FOLFOX * nivolumab, capecitabine, oxaliplatin * nivolumab, 5-Fluorouracil, leucovorin, oxaliplatin
- Experimental: Arm DSonesitatug vedotin + Capecitabine
- Active Comparator: Arm EZolbetuximab + CAPOX or Zolbetuximab + FOLFOX: * zolbetuximab, capecitabine, oxaliplatin * zolbetuximab, 5-Fluorouracil, leucovorin, oxaliplatin CAPOX or FOLFOX: * oxaliplatin, capecitabine, * 5-Fluorouracil, leucovorin, oxaliplatin
Primary Outcome Measure
Progression Free Survival (PFS) (Cohort 1 and Cohort 2) [ Time Frame: Up to approximately 5 years ]
Central Contacts
- AstraZeneca Clinical Study Information Center1-877-240-9479
Locations (77)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Research Site | Phoenix | Arizona | 85054 | - |
| Research Site | Springdale | Arkansas | 72762 | - |
| Research Site | Duarte | California | 91010 | - |
| Research Site | Fullerton | California | 92835 | - |
| Research Site | La Jolla | California | 92093 | - |
| Research Site | Los Alamitos | California | 90720 | - |
| Research Site | Orange | California | 92868 | - |
| Research Site | Walnut Creek | California | 94598 | - |
| Research Site | Denver | Colorado | 80210 | - |
| Research Site | Lone Tree | Colorado | 80124 | - |
| Research Site | New Haven | Connecticut | 06510 | - |
| Research Site | Newark | Delaware | 19713 | - |
| Research Site | Washington D.C. | District of Columbia | 20007 | - |
| Research Site | Fort Myers | Florida | 33901 | - |
| Research Site | Jacksonville | Florida | 32224 | - |
| Research Site | Orlando | Florida | 32806 | - |
| Research Site | St. Petersburg | Florida | 33705 | - |
| Research Site | West Palm Beach | Florida | 33401 | - |
| Research Site | Atlanta | Georgia | 30309 | - |
| Research Site | Atlanta | Georgia | 30322 | - |
| Research Site | Atlanta | Georgia | 30342 | - |
| Research Site | Macon | Georgia | 31201 | - |
| Research Site | Newnan | Georgia | 30265 | - |
| Research Site | Chicago | Illinois | 60637 | - |
| Research Site | Niles | Illinois | 60714 | - |
| Research Site | Zion | Illinois | 60099 | - |
| Research Site | Indianapolis | Indiana | 46260 | - |
| Research Site | Waukee | Iowa | 50263 | - |
| Research Site | Lexington | Kentucky | 40536 | - |
| Research Site | Louisville | Kentucky | 40217 | - |
| Research Site | Boston | Massachusetts | 02114 | - |
| Research Site | Burlington | Massachusetts | 01803 | - |
| Research Site | Grand Rapids | Michigan | 49503 | - |
| Research Site | Burnsville | Minnesota | 55337 | - |
| Research Site | Duluth | Minnesota | 55805 | - |
| Research Site | Rochester | Minnesota | 55905 | - |
| Research Site | Kansas City | Missouri | 64132 | - |
| Research Site | St Louis | Missouri | 63110 | - |
| Research Site | Camden | New Jersey | 08103 | - |
| Research Site | East Brunswick | New Jersey | 08816 | - |
| Research Site | Hackensack | New Jersey | 07601 | - |
| Research Site | New Brunswick | New Jersey | 08901 | - |
| Research Site | Summit | New Jersey | 07901 | - |
| Research Site | New York | New York | 10029 | - |
| Research Site | New York | New York | 10032 | - |
| Research Site | New York | New York | 10065 | - |
| Research Site | The Bronx | New York | 10461 | - |
| Research Site | The Bronx | New York | 10468 | - |
| Research Site | White Plains | New York | 10601 | - |
| Research Site | Charlotte | North Carolina | 28204 | - |
| Research Site | Winston-Salem | North Carolina | 27103 | - |
| Research Site | Cleveland | Ohio | 44195 | - |
| Research Site | Columbus | Ohio | 43221 | - |
| Research Site | Portland | Oregon | 97213 | - |
| Research Site | Portland | Oregon | 97239 | - |
| Research Site | Hershey | Pennsylvania | 17033 | - |
| Research Site | Philadelphia | Pennsylvania | 19104 | - |
| Research Site | Pittsburgh | Pennsylvania | 15232 | - |
| Research Site | Pittsburgh | Pennsylvania | 15240 | - |
| Research Site | Wilkes-Barre | Pennsylvania | 18711 | - |
| Research Site | York | Pennsylvania | 17403 | - |
| Research Site | Charleston | South Carolina | 29425 | - |
| Research Site | Sioux Falls | South Dakota | 57105 | - |
| Research Site | Memphis | Tennessee | 38104 | - |
| Research Site | Nashville | Tennessee | 37203 | - |
| Research Site | Dallas | Texas | 75235 | - |
| Research Site | Dallas | Texas | 75246 | - |
| Research Site | Sherman | Texas | 75090 | - |
| Research Site | Blacksburg | Virginia | 24060 | - |
| Research Site | Fairfax | Virginia | 22031 | - |
| Research Site | Falls Church | Virginia | 22042 | - |
| Research Site | Fort Belvoir | Virginia | 22060 | - |
| Research Site | Richmond | Virginia | 23219 | - |
| Research Site | Olympia | Washington | 98502 | - |
| Research Site | Seattle | Washington | 98104 | - |
| Research Site | Charleston | West Virginia | 25315 | - |
| Research Site | Milwaukee | Wisconsin | 53226 | - |
Find similar trials in Phoenix, AZ
By condition
By specialty
Related Studies
- Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of LifeRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- Esophageal Cancer Risk RegistryRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer PatientsRecruiting · Vanderbilt University Medical Center · Nashville, Tennessee
- Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal VolunteersRecruiting · University of Colorado, Denver · Aurora, Colorado